Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04287647 · ClinicalTrials.gov registry record · NA
Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis
A NA study of Gastroparesis, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT04287647 is a NA study of Gastroparesis that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 36 participants, below the 301-participant average among 44 other Gastroparesis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04287647, a NA study of Gastroparesis, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective sham study to investigate the role of transpyloric stenting with lumen apposing metal stent (LAMS) as a predictor for clinical response to gastric per-oral endoscopic pyloromyotomy (GPOEM) for refractory gastroparesis. The study hypothesizes that clinical improvement with transpyloric stenting in patients with refractory gastroparesis is a predictor of subsequent clinical success of GPOEM.
Conditions Studied
Interventions
- OTHER Sham
- DEVICE Transpyloric stent
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2026-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04287647
The ClinicalTrials.gov registry entry for NCT04287647 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 44 other Gastroparesis trials with a reported enrollment target (88% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT04287647 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04287647 about?
NCT04287647 is a clinical study titled "Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis". This is a prospective sham study to investigate the role of transpyloric stenting with lumen apposing metal stent (LAMS) as a predictor for clinical response to gastric per-oral endoscopic pyloromyotomy (GPOEM) for refractory gastroparesis. The study hypothesizes that clinical improvement with trans...
What is the current status of trial NCT04287647?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2019-05-15. Estimated completion is 2026-06-06.
What conditions does trial NCT04287647 study?
This clinical trial studies the following conditions: Gastroparesis.
What interventions are being tested in trial NCT04287647?
The interventions under investigation include: Sham (OTHER), Transpyloric stent (DEVICE).
Who is sponsoring clinical trial NCT04287647?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04287647 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
RECRUITING · NA
-
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
RECRUITING · NA
-
Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.